Today's Health News

USPSTF Presents New Approach to Sex, Gender in Recommendations

Task force will use inclusive approach to identify issues related to sex, gender in guideline development; will use gender-neutral language

BNT162b2 Highly Effective Against Delta Variant in Teens

At seven to 21 days after second dose, estimated effectiveness was 90 percent against infection, 93 percent against symptomatic COVID-19

3 Percent of U.S. Cancer Cases Attributable to Physical Inactivity

Population-attributable fraction varied from 3.9 percent for urinary bladder cancer to 16.9 percent for stomach cancer

Proton Pump Inhibitor Use Tied to Less Severe Periodontal Disease

Patients with periodontitis who use proton pump inhibitors have fewer teeth with elevated probing depths for the gap between teeth and gums

Fibrosis Stages F3, F4 in NAFLD Linked to Higher Mortality Risk

Incidence of all-cause mortality increased with increasing fibrosis stage; increase also seen in liver-related complications

Lanifibranor Reduces Disease Activity in Nonalcoholic Steatohepatitis

In phase 2b trial, more patients with active NASH had reduction in disease activity score with lanifibranor versus placebo

Salmonella Outbreak in 37 States Linked to Imported Onions

So far, there have been 129 hospitalizations, but no deaths

ACG Updates Clinical Guidelines for Benign Anorectal Disorders

Anorectal biofeedback therapy recommended in defecation disorders; biofeedback also recommended in proctalgia syndrome

More Than Half of COVID-19 Survivors Have Postacute Sequelae

Most common sequelae include functional mobility impairments, pulmonary abnormalities, and mental health disorders

FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases

Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis